CClinicalTrials.gg
Status unknownNCT02134444Updated Jan 8, 2016

Game Based Vestibular Exercise for Home Rehabilitation

An interventional study of Experimental group and Control group in Peripheral Vestibular Disorders and Dizziness, sponsored by University of Manitoba. Status unknown at 1 site in Canada. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-01-08.

Sponsored by University of Manitoba · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Study summary

Study Description and Purpose:

The vestibular sense organs of the inner ear consist of the semi-circular canals and otolith end organs. These organs contain specialized gravito-inertial sensors that sense angular and linear head acceleration. The input from these sensors is required to stabilize gaze position during head motion, and provide an absolute frame of reference with respect to gravity, thus providing a vertical spatial reference for body orientation and balance. Disease or damage of the vestibular sense organs causes a range of distressing symptoms and functional problems for people that could include loss of balance, gaze instability, disorientation and dizziness. A novel computer based rehabilitation system with therapeutic gaming application has been developed. This method allows different gaze and head movement exercises to be coupled to a wide range of inexpensive, commercial computer games. It can be used in standing and thus graded balance demands using a sponge pad can be incorporated into the program.

Study Objective:

  1. Test the therapeutic effectiveness of the TRP delivered in the home compared to usual care delivered in an out-patient physical therapy clinic on measures of balance (standing and walking) , gaze control, dizziness, and health related quality of life in individuals with peripheral vestibular disorders.
  2. Compare trajectory of change in electronic gaze performance measures obtained during each therapy session of each participant assigned to the home Telerehabilitation.

Hypothesis:

Investigators believe the Telerehabilitation platform to be a cost-effective delivery of rehabilitation. Additionally motivation to perform tedious home programs can be improved with engaging, fun and interactive computer gaming as part of the rehabilitation process. It is hypothesized the home game-based Telerehabilitation program will result in greater improvements in dynamic balance control, gaze control, and dizziness, in individuals with peripheral vestibular disorders as compared to a typical out-patient physical therapy regimen.

Read the detailed description

Protocol

Design \& Methodology:

This study will adopt a randomized clinical trial design. Recruitment and screening (including diagnostics) will be coordinated by co-applicant, Dr. Jordon Hochman, department of Otolaryngology, Karen Reimer, and Andrea Giacobbo,; Physical Therapists.

Inclusion criteria:

Consist of (a) age 18 to 65 , (b) diagnosed with unilateral peripheral vestibular hypo function based on a detailed neuro-otological and neuro-orthoptic analysis to include binocular electro-oculography with caloric testing, and (c) have a home computer running Windows or Mac OS.

Exclusion criteria:

Consist of those with CNS disorders for example CVA, Multiple Sclerosis, epilepsy, migraines, concussion recent fractures of the lower extremities or vertebra, advanced hip/knee OA , and cardiac disease. Participants will be randomly assigned to either the Control group (active comparator) or Experimental group (therapeutic gaming). Participants will be blinded to the treatment. The treating therapist will know who is receiving the home or out-patient clinical program.

Control group will receive; (a) Herdman gaze stabilization exercises, (b) optokinetic exercises, and (c) balance exercises using sponge pads. These exercises are presently a standard of vestibular care. Participants will attend an out-patient physical therapy clinic once a week for 8-10 weeks. The program also includes a 20 minute home exercise program prescribed four times per week.

Experimental group: Will receive the game-based rehabilitation program delivered at home. The program for gaze will include provision of the motion mouse (Gyration). This approach provides a highly flexible treatment tool applied to train gaze control, and allows incorporation of graded balance demands. The use of this HID compliant computer input device allows many different therapeutic exercises to be coupled to a wide range of inexpensive commercial computer games. Though initially designed for clinical use, with the easy to use and inexpensive motion sense mouse and computer games this intervention approach can be extended to home settings. Many therapeutic exercises and activities (singly or in combination) can be used to practice a variety of gaze and balance skills, and, importantly, while playing fun computer games.

Participants will attend three clinical sessions during which time the home therapy programs will be established and training in the use of the computer, motion mouse and games will be provided. Based on clinical experience and pilot data, three sessions is sufficient before initiating the home program.16 The treating physiotherapist will attend the participant's home to ensure proper set-up and operation of the TRP equipment and computer applications. Participants will be asked to perform their respective home programs four times per week for 20 minutes per session. They will receive a phone call at one week to assess their ability to manage their home program. Thereafter participants will attend for clinical follow-up once per month.

Recording and Data Analysis The following information will be collected at baseline prior to start of the interventions; age, gender, work history, occupation and (history of disease/injury process, and current medications. Assessor will be blinded to participant assignments.

Primary Outcome Measures:

  1. Clinical Test of Sensory Interaction in Balance (CTSIB); performance-based measure of balance under altered sensory conditions).
  2. Dizziness Handicap Inventory (DHI), is a self-rating questionnaire based on 25 questions used to quantify a client's perception of his or her dizziness and its impact on their life.

Secondary outcome measures:

  1. Computerized Visual tracking test (CVT), involves tracking a bright visual target moving horizontally left and right on a computer display in a sinusoidal fashion for several cycles, and at predetermined speeds. The application records (80 Hz) coordinates of both reference and head cursors. Coefficient of determination (COD) will be computed based on total and average residual difference between trajectories of the reference and head cursor motions. A value approaching one equates to excellent gaze performance. This test will be performed in standing and while walking on a treadmill at 0.9 m/s.
  2. Participants in the experimental group will be given the visual tracking game application for home use. The game software automatically logs reference and head cursor coordinates (gaze performance) during the visual tracking task and saves the data to a coded and time stamped computer file (anatomized). Participants will be asked to play the tracking task (in standing at the beginning of every training session. This will involve three short tests of 45 seconds at three tracking speeds. The application automatically saves the logged data file, and the clients can either e-mail the files to the investigator, or save on a flash drive provided and return at a follow-up visit.
  3. Spatiotemporal gait variables and walking stability measures. This is included to examine whether the exercise program transfers to walking. A treadmill instrumented with a pressure mat (Vista Medical, CA) will be used to record vertical foot forces for each step during walking trials of 1 minute at 0.9 m/s, and thus data for 40 consecutive steps.
  4. Participants will be ask to complete a log of dates and duration of each exercise session, and submit either a paper version or by e-mail.

Statistical Analysis \& Power Assessment: Descriptive statistics, including means, standard deviations, frequencies, and percentages, will be used to describe the experimental and control groups on the baseline demographic variables. Differences between the groups on the outcomes will be tested using t-tests and tests of independence.

To achieve Objective 1, we will test the difference between experimental and control groups on continuous and normally distributed outcome measures using analysis of covariance, with the dependent variable being the post-intervention measurement of the outcome, the covariate being the pre-intervention measurement, and group membership as the between-subjects effect. Descriptive statistics, including measures of skewness and kurtosis, will be used to assess departures from the assumptions of a normal distribution of responses. If the distribution contains extreme observations, a robust ANCOVA statistic will be adopted. To test differences between experimental and control groups on discrete outcomes, such as counts of number of times participants feel dizzy during their daily activities, we will use a Poisson regression model, with the dependent variable being a count of the number of relevant events, the covariate being the pre-intervention measurement, and group membership as the between-subjects effect.

To analyze the longitudinal data associated with Objective 2, we will use a mixed-effects regression model with time as the random effect and group as the fixed effect. This model will be adopted because it accounts for clustering of repeated measurements within study participants and uses all available longitudinal data (i.e., it does not result in case-wise deletion of study participants due to missing observations.

Based on pilot data for the primary outcome (i.e., CTSIB), we conducted a power analysis of the required sample size to test the difference between the experimental and controls groups at the post-intervention measurement occasion (i.e., objective 1). The pilot data showed a standardized effect size of 0.80. Assuming the number of model covariates to be 3, the proportion of variance explained by these covariates to be 10%, and a two-tailed test of the null hypothesis of no group difference at p = .05, a sample size of 46 is required. We expect an attrition rate of 20% over the study observation period for objective 2. Given this, we propose to recruit a sample of N = 56 individuals to participate, with equal numbers to be recruited to the treatment and control groups.

02

Conditions studied

  • Peripheral Vestibular Disorders
  • Dizziness

Keywords

  • Dizziness
  • Vertigo
  • Vestibular Diseases
  • Vestibular Neuritis
  • Labyrinth Diseases
  • Ear Diseases
  • Vestibular rehabilitation
  • Telerehabilitation
  • Gaze control
  • Balance
03

In context

Vertigo

248 studies on the registry are indexed under Vertigo; 39 are open to participants now.

This study's planned enrollment of 50 is below the median of 57 across 186 interventional studies indexed under Vertigo.

Browse Vertigo studies →

Lead sponsor

University of Manitoba is the lead sponsor of 542 studies on the registry; 87 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age between 20-60
  2. English speaking
  3. Diagnosed with unilateral or bilateral peripheral vestibular hypo function based on a detailed neuro-otological and neuro-orthoptic analysis to include binocular electro-oculography with caloric testing;
  4. Have a home computer running Windows or Mac OS. 5 Adequate hearing and vision acuity

Exclusion criteria

Exclusion Criteria:

  1. Those with CNS disorders for example CVA, Multiple Sclerosis, epilepsy, migraines.
  2. Recent fractures of the lower extremities or vertebra, advanced hip/knee OA ,
  3. Cardiac disease .
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    Experimental group will receive the assigned intervention which is a game-based rehabilitation program delivered at home.

    Behavioral: Experimental group

  • Active comparator
    Control group

    Control group will receive a vestibular rehabilitation program which will include the Herdman gaze stabilization exercises and balance training program.

    Behavioral: Control group

Interventions

  • BehavioralExperimental group

    Experimental group will receive a game-based exercise program delivered at home. This includes provision of a head-mounted motion mouse. This provides a treatment tool applied to gaze control, and allows incorporation of balance exercises. It also allows many different therapeutic exercises to be coupled to a wide range of inexpensive commercial computer games. Participants will attend 3 clinical sessions during which time the home therapy programs will be established and training in the use of the motion mouse and games will be provided. The treating physiotherapist will attend the participant's home to ensure proper set-up and operation of the computer applications. Participants will be asked to perform their respective home programs four times per week for 20 minutes per session.

  • BehavioralControl group

    Control group will receive a vestibular exercise program which will include the Herdman gaze stabilization exercises and balance training program. This program is presently a standard of vestibular care. Participants will attend an out-patient physical therapy clinic once a week for 12 weeks. The program also includes a 20 minute home exercise program prescribed 4 times per week.

06

What researchers measure

Primary outcomes

  1. Standing Balance

    This will be measured by performing a) Clinical Test of Sensory Integration of Balance and b) Five - Time Sit-to-Stand Test. Centre of Foot Pressure (COP) is recorded during test conditions and root mean square (RMS) and total Path Length ) in Medial-Lateral and Anterior-Posterior Directions is quantified.

    Time frame: Pre and post intervention of 12 weeks

  2. Dizziness Handicap Inventory (DHI)

    It is a self-rating questionnaire based on 25 questions used to quantify a client's perception of his or her dizziness and its impact on their life.

    Time frame: Pre and post intervention of 12 weeks

  3. Computerized Visual Tracking Performance

    A computer application has been developed which involves tracking a bright visual target moving horizontally left and right on a computer display in a sinusoidal fashion for several cycles, and at predetermined speeds. This procedure requires vestibular function and smooth pursuit to coordinate eye and head motions during the active head tracking task. The computer application records (80 Hz) coordinates of both reference and head cursors. Coefficient of determination (COD) will be computed based on total and average residual difference between trajectories of the reference and head cursor motions. A value approaching one equates to excellent gaze performance. This test will be performed in sitting, standing and while walking on a treadmill at 0.9 m/s

    Time frame: Pre and post intervention of 12 weeks

  4. Spatial - temporal gait variables during treadmill walking with and without visual tracking task.

    It will be measured by asking the participants to walk on a treadmill for 1 minute which is instrumented with a pressure mat at a speed of 0.9 m/s. Average and coefficient of variation will be obtained for the following parameters: swing time, step time, step length and step width. Participants will repeat the: 1. Baseline walk not engaged in any visual tracking or head movement task 2. While performing the CDVA visual tracking task described above for 45 seconds

    Time frame: Pre and post intervention of 12 weeks

07

Study locations

1 of 1 sites recruiting
  • University of Manitoba
    Winnipeg, Manitoba R3E 0T6, Canada
    Recruiting
08

References and documents

Publications

  • Szturm T, Betker AL, Moussavi Z, Desai A, Goodman V. Effects of an interactive computer game exercise regimen on balance impairment in frail community-dwelling older adults: a randomized controlled trial. Phys Ther. 2011 Oct;91(10):1449-62. doi: 10.2522/ptj.20090205. Epub 2011 Jul 28. PubMed 21799138 ↗
  • Desai A, Goodman V, Kapadia N, Shay BL, Szturm T. Relationship between dynamic balance measures and functional performance in community-dwelling elderly people. Phys Ther. 2010 May;90(5):748-60. doi: 10.2522/ptj.20090100. Epub 2010 Mar 11. PubMed 20223944 ↗
  • Szturm T, Maharjan P, Marotta JJ, Shay B, Shrestha S, Sakhalkar V. The interacting effect of cognitive and motor task demands on performance of gait, balance and cognition in young adults. Gait Posture. 2013 Sep;38(4):596-602. doi: 10.1016/j.gaitpost.2013.02.004. Epub 2013 Mar 9. PubMed 23477841 ↗
  • Szturm T, Wu c. etal. (2013). Technology-assisted & motivational program for a blended approach to manage balance gaze mobility and cognitive decline with age. OA Evidence-Based Med. Apr;1):1.
  • Lockery D, Peters JF, Ramanna S, Shay BL, Szturm T. Store-and-feedforward adaptive gaming system for hand-finger motion tracking in telerehabilitation. IEEE Trans Inf Technol Biomed. 2011 May;15(3):467-73. doi: 10.1109/TITB.2011.2125976. PubMed 21536526 ↗
  • Szturm T, Hochman J, Wu C, Lisa L, Reimer K, Wonneck B, Giacobbo A. Games and Telerehabilitation for Balance Impairments and Gaze Dysfunction: Protocol of a Randomized Controlled Trial. JMIR Res Protoc. 2015 Oct 21;4(4):e118. doi: 10.2196/resprot.4743. PubMed 26490109 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02134444
Lead sponsor
University of Manitoba
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Sponsor
First posted
May 9, 2014
Start date
May 2014
Primary completion
May 2016 (estimated)
Completion
May 2016 (estimated)
Last update
Jan 8, 2016

Study contacts

Tony Szturm, PT, PhD
Contact
tony.szturm@med.umanitoba.ca
204-787-4794
Tony Szturm, PT, PhD
principal investigator · University of Manitoba
Jordan Hochman, MD
principal investigator · University of Manitoba
Lisa Lix, PhD
principal investigator · University of Manitoba
Christine Wu
principal investigator · University of Manitoba
Karen Reimer, PT, M.Sc.
principal investigator · Private Practice Clinician
Andrea Giacobbo, PT
principal investigator · Private Practice Clinician

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion